State-by-State Telehealth Prescribing Rules for GLP-1 Drugs
Telemedicine practice standards are set at the state level in the U.S., which means the rules governing a GLP-1 telehealth prescription can change at a state line.
By the GLP Semaglutide editorial team · Last updated June 25, 2026
Medical licensure and telemedicine practice standards are regulated at the state level in the U.S. A clinician generally needs to be licensed in the state where the patient is physically located at the time of the visit, not just where the clinician or platform is based.
What states commonly require
Requirements vary, but commonly include some form of clinical evaluation before prescribing, informed consent disclosures, and record-keeping standards — with some states requiring a live (synchronous) visit and others permitting asynchronous, questionnaire-based evaluation for certain prescriptions.
Check your state medical board
Because these rules are state-specific and have been actively revised in several states, a state medical board's current telemedicine guidance is the authoritative source, not general summaries.
Primary sources